CYTOGRAFT TISSUE ENGINEERING, INC.

Company Information
Address 3 HAMILTON LANDING, STE 220
NOVATO, CA, 94949-


Information

DUNS:

# of Employees: N/A


Ownership Information

HUBZone Owned: N

Socially and Economically Disadvantaged: N

Woman Owned: N



Award Charts




Award Listing

  1. Tau Protein Aggregation Inhibitors for Tauopathies

    Amount: $207,689.00

    DESCRIPTION (provided by applicant): Transcatheter aortic valve implantation (TAVI) is a minimally invasive approach to valve replacement that has had a rapid and profound clinical impact. Less than t ...

    SBIRPhase I2013Department of Health and Human Services
  2. Cell-synthesized Thread-based Tissue Engineering

    Amount: $1,473,645.00

    DESCRIPTION (provided by applicant): Cardiovascular disease is the leading cause of death in industrialized nations. While interventional techniques such as angioplasty and/or stenting can often dela ...

    SBIRPhase II2011Department of Health and Human Services
  3. Cell-synthesized Thread-based Tissue Engineering

    Amount: $215,415.00

    DESCRIPTION (provided by applicant): Previously, we have reported excellent clinical results with a tissue engineered vascular graft built using a self-assembly approach termed Sheet-Based Tissue Eng ...

    SBIRPhase I2010Department of Health and Human Services
  4. Development of a Biological Stent Graft for Aorta Aneurysm Repair

    Amount: $214,912.00

    DESCRIPTION (provided by applicant): Abdominal aorta aneurysms (AAA) are diagnosed in more than 100,000 patients in the U.S. each year. About 70% of these patients require surgical intervention to pre ...

    SBIRPhase I2010Department of Health and Human Services
  5. Commercialization of a Tissue Engineered Blood Vessel

    Amount: $2,482,150.00

    DESCRIPTION (provided by applicant): The stated objective for this PA is to fund pre-clinical and clinical tests to support regulatory requirements for promising medical technologies. Accordingly, th ...

    SBIRPhase II2005Department of Health and Human Services
  6. in vivo Evaluation of a Tissue Blood Vessel

    Amount: $0.00

    DESCRIPTION (provided by applicant): Coronary heart disease is the leading cause of death in the industrialized world. Despite advances in catheter-based interventions, bypass remains the treatment ...

    SBIRPhase I2003Department of Health and Human Services
  7. N/A

    Amount: $98,880.00

    N/A

    SBIRPhase I2000Department of Health and Human Services

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government